Faeth Therapeutics, Inc. (FTH) vs Olema Pharmaceuticals, Inc. (OLMA)
A side-by-side comparison of Faeth Therapeutics, Inc. and Olema Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FTH
Faeth Therapeutics, Inc.
$26.89HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OLMA
Olema Pharmaceuticals, Inc.
$7.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — FTH vs OLMA
growth of $100 · dividends reinvested · last 6yFTH -92.8% (-35.5%/yr)OLMA -80.7% (-24.0%/yr)OLMA compounded faster over this window
FTH OLMA
FTH vs OLMA: by the numbers
- •FTH is the larger company ($693M vs $692M market cap).
Metrics side by side
Valuation
| Metric | FTH | OLMA |
|---|---|---|
| P/B ratio | 4.01 | 1.61 |
Profitability
| Metric | FTH | OLMA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -113.05% | -47.51% |
| ROIC | -110.62% | -50.92% |
Growth (annualized)
| Metric | FTH | OLMA |
|---|---|---|
| Total return CAGR (5Y) | -31.75% | -21.50% |
Frequently asked
- How have FTH and OLMA total returns compared?
- Over the past 5 years, FTH delivered -31.75% and OLMA delivered -21.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.